Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 72,600
-1,400 (-1.89%)
Sep 10, 2026, 9:15 AM KST
Mezzion Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,264,844 | 2,735,789 | 924,369 | 1,153,908 | 347,646 | 1,932,235 | |
Market Cap Growth | 34.78% | 195.96% | -19.89% | 231.92% | -82.01% | 23.60% |
Enterprise Value | 2,241,851 | 2,718,222 | 891,105 | 1,093,258 | 314,521 | 1,903,261 |
Last Close Price | 74000.00 | 90100.00 | 30850.00 | 39000.00 | 13000.00 | 72366.67 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 71.28 | 71.28 | 71.28 | 71.28 | 71.28 |
PS Ratio | 268.71 | 345.89 | 107.34 | 36.38 | 11.31 | 72.49 |
PB Ratio | 58.01 | 159.11 | 20.07 | 18.78 | 13.25 | 30.77 |
P/TBV Ratio | 60.52 | 175.66 | 20.80 | 19.29 | 14.12 | 31.59 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 265.99 | 343.67 | 103.48 | 34.47 | 10.24 | 71.41 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.44 | 0.69 | 0.04 | 0.04 | 0.04 | 0.07 |
Net Debt / Equity Ratio | -0.59 | -0.80 | -0.59 | -0.91 | -1.19 | -0.69 |
Net Debt / EBITDA Ratio | 1.28 | 0.86 | 2.02 | 4.33 | 1.45 | 2.84 |
Net Debt / FCF Ratio | 1.12 | 0.82 | 1.42 | 4.85 | 2.44 | 2.80 |
Asset Turnover | 0.08 | 0.09 | 0.10 | 0.43 | 0.45 | 0.33 |
Inventory Turnover | 1.31 | 1.22 | 1.20 | 3.82 | 3.01 | 2.44 |
Quick Ratio | 0.49 | 0.34 | 1.12 | 2.12 | 1.35 | 2.72 |
Current Ratio | 0.68 | 0.57 | 1.57 | 2.51 | 1.76 | 3.47 |
Return on Equity (ROE) | -68.28% | -110.43% | -36.23% | -29.03% | -81.54% | -22.75% |
Return on Assets (ROA) | -11.01% | -12.24% | -10.76% | -12.39% | -21.14% | -13.16% |
Return on Invested Capital (ROIC) | -142.13% | -149.32% | -116.73% | -8454.47% | -321.28% | -103.59% |
Return on Capital Employed (ROCE) | -47.10% | -91.30% | -30.20% | -23.20% | -83.50% | -25.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.21% | -1.28% | -2.11% | -1.10% | -10.44% | -0.70% |
FCF Yield | -0.91% | -0.61% | -2.06% | -1.00% | -3.69% | -0.80% |
Buyback Yield / Dilution | -1.36% | -0.98% | -5.62% | -5.63% | -0.17% | -2.63% |